Company news
Avecho Biotechnology Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Improved Propofol TPM Formulation Passes Toxicology Study
November 3, 2020
September 2020 Quarterly Activities Report & Appendix 4C
October 28, 2020
TPM Cannabinoid Development Program Update
October 18, 2020
Progress Update for TPM Cannabinoid Development Program
August 19, 2020
June 2020 Quarterly Activities Report & Appendix 4C
July 28, 2020
March 2020 Quarterly Activities Report & Appendix 4C
April 28, 2020
Changes to Leadership Team
April 26, 2020
Medicinal cannabis supply agreement with Tasmanian Alkaloids
April 26, 2020
Avecho signs Term Sheet for Cannabinoid Supply with Purisys
April 13, 2020
Appendix 4E and Annual Report 31 December 2019
March 1, 2020
Appendix 4C - Quarterly
January 22, 2020
Injectable Portfolio Update - Products Differentiated by TPM
December 4, 2019
Terumo return rights to TPM/Propofol Injectable
October 16, 2019
Ashland purchases manufacturing rights for Vital ET and TPM
June 19, 2019
FDA meeting provides guidance for TPM/Oxymorphone patch
January 17, 2019
Reinstatement to Offical Quotation
December 18, 2018
Phosphagenics and Mylan Agree Settlement
December 18, 2018
Suspension from Official Quotation
December 11, 2018
Phosphagenics Arbitration Award Issued
November 11, 2018
Phosphagenics Receives Further Arbitration Process Update
October 22, 2018
Phosphagenics Licensing Agreement Update
September 9, 2018
Half Year Accounts
August 13, 2018
AGM Chairmans Address and CEO Presentation
May 24, 2018
Terumo Shifts Focus From Oxymorphone Patch to Injectables
March 19, 2018
Preliminary Final Report
February 27, 2018
Phosphagenics Placement Secures A$1.37 million
January 17, 2018
Phosphagenics Receipt of R&D Tax Incentive
January 16, 2018
Phosphagenics Announces Results of Dairy Trial
December 21, 2017
TPM Improves Negative Effects of Heat Stress in Poultry
December 14, 2017
Phosphagenics Multinational License for TPM in Personal Care
December 3, 2017
Phosphagenics Update on TPM/Propofol Development Program
November 8, 2017
Phosphagenics Entitlement Offer Information Booklet
October 3, 2017
Phosphagenics Announces Equity Raising
September 26, 2017
Phosphagenics Signs Term Sheet TPM Diclofenac Gel in Asia
September 25, 2017
Phosphagenics Market Update - Potential Return of Capital
September 1, 2017
June 2017 Half-year Financial Report and Appendix 4D
August 31, 2017
Phosphagenics Signs Patch Development Agreement with Terumo
August 22, 2017
Phosphagenics Sells BioElixia Brand to Pure Beauty Australia
August 9, 2017
POH Mylan Arbitration Update- Expert Report on Damages Filed
May 28, 2017
Phosphagenics and IAH Cease All Partnerships
March 9, 2017
Appendix 4E and Annual Financial Report
February 28, 2017
Phosphagenics Non-Binding Term Sheet for OxyM Patch in Japan
January 30, 2017
Phosphagenics Poultry Feed Study Reports Positive Data
December 14, 2016
Reformulation TPM/Oxymorphone Complete
December 11, 2016
Phosphagenics ProPhase Arbitration Ruling Handed Down
November 16, 2016
S&P DJ Indices Announces March Quarterly Rebalance
November 7, 2016
Phosphagenics Updates Long Term Incentive Scheme
September 11, 2016
Phosphagenics Begins Feed Efficiency Study in Poultry
August 31, 2016
June 2016 Half-year Financial Report and Appendix 4D
August 25, 2016
Phosphagenics Completes Grower/Finisher Pig Study
June 29, 2016
Decks
The 5 newest of 23 decks. Every deck is listed under its year.
- Canaccord Genuity Drug & Device Conference 2026
Conference · 12 slides · Oct 13, 2026
- ASX SMIDcaps Conference 2026
Conference · 11 slides · Sep 23, 2026
- Shareholder Meeting (May 2026)
Shareholder meeting · 22 slides · May 26, 2026
- Corporate Update (May 2026)
Corporate update · 13 slides · May 25, 2026
- AusBiotech Invest 2025
Conference · 10 slides · Oct 21, 2025